Ose Immunotherapeutics is a clinical-stage biotechnology company that develops innovative immunotherapies for activation and regulation of the immune system in Immuno-Oncology and Immuno-Inflammation.
peer of
Metrics
marketPRIVATE
msh_idCOM:OSE-IMMUNO
localefr
websitehttps://ose-immuno.com/
source_ref243cc1e2-f6e1-41f2-b8ef-4aff37233327
products_or_servicesImmunotherapies including Tedopi®, OSE-279, OSE-127/Lusvertikimab, FR104/VEL-101, BI 770371, ABBV-230, and CLEC-1.
France